Assessment of Osseointegration Properties of Nano-Hydroxy Apatite Coated Titanium Implant
1 other identifier
interventional
30
1 country
1
Brief Summary
the purpose of this trial is to evaluate the osseointegration properties of nano-hydroxy apatite coated titanium implants in posterior maxilla. 30 patients will be included in this trial divided into two groups, control and intervention. Primary and secondary implant stability will be measured
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2023
CompletedStudy Start
First participant enrolled
June 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 5, 2024
CompletedApril 9, 2024
April 1, 2024
9 months
June 22, 2023
April 8, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Implant stability
implant stability will be measured by radiofrequency analysis
immediately post-operative
Implant stability
implant stability will be measured by radiofrequency analysis
4 weeks post-operative
Implant stability
implant stability will be measured by radiofrequency analysis
6 weeks post-operative
Implant stability
implant stability will be measured by radiofrequency analysis
12 weeks post-operative
Study Arms (2)
Nano-hydroxy apatite arm
EXPERIMENTALin this groups patients will receive nano-hydroxy apatite coated titanium implants
SLA arm
ACTIVE COMPARATORin this group patients will receive sandblasted large thread acid etched titanium implants
Interventions
titanium implants with surface treatment of nano-hydroxy apatite
titanium implants with SLA surface treatment
Eligibility Criteria
You may qualify if:
- Patients with missing at least one maxillary posterior tooth
- Patients free from any systemic disease
- Patients who approve to be included in the trial and sign the informed consent
- Patients with no intra-bony defect.
- Adults aged 18 years old and above
You may not qualify if:
- Patients who are allergic to titanium
- Heavy smoker patient
- Patients receiving chemotherapy or radiotherapy
- Patients who refused to be included in the trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
October University for Modern Sciences and Arts faulty of Dentistry
Giza, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Mohamed H Mahmoud, PhD
october university for modern science and arts faculty of dentistry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
June 22, 2023
First Posted
July 10, 2023
Study Start
June 22, 2023
Primary Completion
April 1, 2024
Study Completion
April 5, 2024
Last Updated
April 9, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share